Blog - Page 1621 of 5724

MondayNov 02, 2020 1:47 pm

QualityStocksNewsBreaks – Why Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Is ‘One to Watch’

Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options. A recent article discussing the company reads, “Headquartered in Hanover, Maryland, Processa has built a pipeline of drugs, which already have proof-of-concept data supporting clinical use in their selected indications. The Processa process focuses on the advancement of drugs that are ready for clinical development or have minimal pre-IND enabling studies to complete. More specifically, Processa: acquires drugs that already have some clinical data to support the targeted treatment; navigates through…

MondayNov 02, 2020 1:23 pm

QualityStocksNewsBreaks – Sanwire Corp. (SNWR) Empowers Artists to Innovate, Create During Pandemic

Sanwire (OTC: SNWR), dedicated to employing digital technologies to provide a wide range of solutions for independent artists, stands to benefit from growing demand in the music industry. According to a report by MIDiA Research, digital technology and social media tools provide independent artists with powerful capabilities to create content and engage with fans during COVID-19 (https://ibn.fm/UH0z1). “This is where Sanwire steps in to fill this growing market need as a company offering digital solutions to empower independent artists with a marketing system specifically built for them,” a recent article reads. “Through its subsidiary Intercept Music, Sanwire provides music artists…

MondayNov 02, 2020 12:32 pm

CYBIN Corp. Set to Benefit from Growing Research, Interest in Psychedelics

Backed by an anonymous donor, Berkeley launches a center for psychedelic science and public education Berkley follows examples of other notable universities such as Johns Hopkins in Maryland, Imperial College in London, and Canadian Centre for Psychedelic Science As an innovative company focusing on psilocybin, CYBIN is set to capitalize on growing academic, commercial attention UC Berkeley is joining other prominent academic institutions, including Johns Hopkins University in Maryland and Imperial College in London, to accelerate the scientific research of psilocybin by launching a new center focusing on the compound (https://ibn.fm/CL4wX). As a mushroom life science company that expects to…

MondayNov 02, 2020 12:06 pm

Knightscope, Inc. Creating Change in the Security Industry Through Proprietary Technology to Assist Law Enforcement and Private Security

Knightscope recently named Ms. Mallorie Burak as Executive Vice President and Chief Financial Officer The company’s autonomous security robots use proprietary technology, combining robotics, self-driving capabilities, and artificial intelligence Game changing technology has now been in operation over 1 million hours and is operating across 5 time zones 24/7/365 Knightscope is a leader in the development of autonomous security capabilities. The company designs and builds Autonomous Security Robots (“ASRs”), which use Knightscope’s proprietary technology combining robotics, self-driving technologies, and artificial intelligence. The ASRs have proven to enhance the safety at hospitals, manufacturing plants, logistics facilities, schools, businesses, parking lots, and…

MondayNov 02, 2020 11:49 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Secures $6.9M in Private Placement

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, earlier this year announced the closing of a private placement financing (the “offering”). According to the update, AzurRx secured approximately $6.9 million in gross proceeds from certain accredited investors, with Alexander Capital LP acting as sole placement agent in the offering. The company intends to use net proceeds to eliminate short- and long-term indebtedness, as well as for general working capital purposes including product development. “We are very grateful for the continued support of our investors,” James Sapirstein, president and CEO of AzurRx said…

MondayNov 02, 2020 11:32 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Preclinical Study Data Show Drug Combo’s Innovative Potential in Fight Against Major Depressive Disorder

Study results have exciting therapeutic potential across wide range of CNS indications. VTGN focused on developing new generation of medications to treat anxiety, depression and more. Company committed to finding treatment to help estimated 264 million people around the world who suffer from depression. Noting that 17.3 million adults in the United States have had at least one major depressive episode and some 264 million people around the world suffer from depression, VistaGen Therapeutics (NASDAQ: VTGN) is committed to finding effective treatments for depression that reach beyond the current standard of care, which includes oral antidepressants and oral atypical antipsychotics.…

MondayNov 02, 2020 11:30 am

QualityStocksNewsBreaks – Knightscope Inc. Secures Purchase Order from California Water District

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations, recently announced its receipt of a purchase order from a California Water District to help protect the supply of clean/safe water to consumers. The company’s advanced physical security technologies hold significant potential in securing indoor or outdoor operations where a security guard or officer is needed. Knightscope further requested that potential clients and decision makers request a demonstration for the company to showcase how its Autonomous Security Robots (“ASRs”) may help with security needs across the U.S. For more details, visit https://ibn.fm/wmR57…

MondayNov 02, 2020 11:03 am

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Announces Granting of Stock Options, Appointment of New CEO

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced that, per its stock option plan, it has granted an aggregate of 1,850,000 incentive stock options to directors, officers and advisors of the company. According to the update, the stock options will vest immediately and be exercisable to purchase one common share in the capital of the company on or before November 2, 2025, at a price of $0.42 per share. In addition, GoldHaven announced the appointment of Daniel Schieber as its chief executive officer and a director…

MondayNov 02, 2020 11:02 am

CNS Pharmaceuticals (NASDAQ: CNSP) Announces Completion of Drug Manufacturing for Brain Cancer Trial

Houston-based CNS Pharmaceuticals is preparing to launch Phase 2 clinical testing of a novel brain cancer-fighting drug candidate called Berubicin early next year The biopharmaceutical company recently announced that a U.S.-based company contracted to make Berubicin has completed its production process and an Italian company working on a dual track in Europe is expected to finish by the end of the year Berubicin has shown promise in combatting Glioblastoma multiforme, an aggressive form of brain cancer commonly regarded as incurable. One participant in Berubicin’s Phase 1 trial remains cancer-free 14 years after the trial CNS Pharmaceuticals, with its sublicensee partner…

MondayNov 02, 2020 10:29 am

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Q3-2020 Results, Notes Significant Strides on Multiple Initiatives

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium in the United States, on Friday reported its financial results for the quarter ended September 30, 2020. In addition, Energy Fuels will host a webcast to review the results at 4:00 p.m. ET on Tuesday, November 3, 2020. Interested parties may join by dialing 1-888-390-0541 (toll free in the U.S. and Canada) and accessing the viewer-controlled webcast slides via the following link: https://ibn.fm/WrPyC. “Energy Fuels made significant strides in the last quarter on our uranium, rare earths and other initiatives,” the company’s president and CEO Mark S. Chalmers…

Site Search

Company Search